Federal Issues
MassBio is front and center on Capitol Hill when it comes to advocating for policies that will pave the way for innovation. We fight for the laws and regulations that will speed the development of treatments and cures for Alzheimer's, Diabetes, HIV/AIDs and other ailments. We advocate for policies that will help bring beneficial therapies to the market and make them available to all.
Federal Legislative News
Massachusetts Congressional Delegation
Massachusetts Senators
Massachusetts Congressional Representatives
The Affordable Care Act
With the implementation of the Affordable Care Act (ACA), which is set to be completed in 2014, MassBio is committed to thoughtful implementation of a law that will have a major impact on the life science industry of the future. Here are four areas of our focus:
1. Biosimilars
4. Independent Payment Advisory Board (IPAB)
Additional Resources
Biotechnology Industry Organization
MassBio Member News
- May 21, 2013 ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2013 ASCO Annual Meeting
- May 17, 2013 ProteomicFx Launches Website And Groundbreaking Kinase Assay
- May 14, 2013 Ce3 Inc.'s Holly Coulter to Present at 2013 "The Inaugural Forum on Optimizing Clinical Research Performance" Conference
- May 9, 2013 David Gammell and Edwin Pease have joined WilmerHale's Boston office as partners in the Corporate Practice
- May 7, 2013 FDA Grants Fast Track Designation for Cubist’s Late-Stage Antibiotic Candidate